Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...
Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports.
BTIG analyst Ryan Zimmerman has maintained their bullish stance on ZBH stock, giving a Buy rating on January 23.Invest with Confidence: Follow ...
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
Zimmer Biomet (NYSE:ZBH) to acquire Paragon 28 (NYSE:FNA) for approximately $1.1B to expand its portfolio in the orthopedic surgical device market. Paragon 28 is Colorado-based medical device company ...
In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...
Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...
Fifth Third Bancorp lessened its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 2.5% in the fourth ...
Zimmer Biomet Holdings Inc. closed 15.92% short of its 52-week high of $133.90, which the company achieved on March 28th.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle ...
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...